TLIS
Talis Biomedical Corp. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website alisbio.com
- Employees(FY) 102
- ISIN US87424L2079
Performance
+4.48%
1W
-3.76%
1M
-3.76%
3M
+13.08%
6M
+16.27%
YTD
+25.53%
1Y
Profile
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also develops Talis One tests for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A and influenza B. The company was incorporated in 2013 and is headquartered in Redwood, California.
Technical Analysis of TLIS 2024-05-31
Overview:
In analyzing the technical indicators for TLIS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for informed deci...
Recent News & Updates
- 2021-09-13 07:00
- 2021-09-09 06:00
- 2021-09-09 03:15
- 2021-09-02 20:49
- 2021-08-31 08:25
- 2021-08-30 04:30
Talis Biomedical Announces CEO Transition(Yahoo Finance)
- 2021-08-11 02:10
- 2021-08-10 04:05
- 2021-08-09 20:25
- 2021-07-26 20:00
- 2021-05-11 20:00
- 2021-05-11 04:05
- 2021-05-11 02:30
Talis Biomedical Corp to Host Earnings Call(Yahoo Finance)
- 2021-05-03 20:00
- 2021-04-27 20:00
- 2021-03-17 20:00
Talis Appoints Jeryl Hilleman to Board of Directors(Yahoo Finance)
- 2021-03-08 21:07
- 2021-03-07 19:00
- 2021-02-17 03:05
- 2021-02-12 04:05
- 2021-02-11 10:39
Talis Announces Pricing of Initial Public Offering(Yahoo Finance)
Page 3 of 3
previousnext